MELISSA AGUIRRE-HOLLAND: Open Payments
NPI 1194021253 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 100 payments from 17 companies in 2025. Trend: 2023 $1,020 · 2024 $2,144 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $268 |
| AstraZeneca Pharmaceuticals LP | 14 | $268 |
| PFIZER INC. | 16 | $201 |
| Lilly USA, LLC | 11 | $176 |
| ABBVIE INC. | 11 | $140 |
| Phathom Pharmaceuticals, Inc. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Eisai Inc. | 3 | $59 |
Products named: AIRSUPRA, VOQUEZNA, JARDIANCE, MOUNJARO, Ozempic, Wegovy, NURTEC ODT, Veozah.
Industry payments across TX — which companies pay providers there.
